Back

Treatment of degenerated aortic bioprostheses: a comparison between conventional reoperation and valve-in-valve transfemoral transcatheter aortic valve replacement

25 August 2018 (11:54 - 12:03)
Organised by:
Congress Presentation Part of: Hot topics in valvular heart disease Treatment, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Georg Maximilian Stachel

Heart Centre Central Clinic Bad Berka, Bad Berka (Germany)

9 More presentations in this session

Presentation thumbnail
Syncope, a underestimated threat in severe aortic stenosis
Doctor G. Goliasch (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Coronary haemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing TAVI: implications for clinical indices of coronary stenosis severity
Doctor Y. Ahmad (London, GB)
Abstract Slides Video
Presentation thumbnail
Analysis of disparities in length of hospital stay after transfemoral transcatheter aortic valve implantation: results from the FRANCE TAVI (FRench Transcatheter Aortic Valve Implantation) Registry
Doctor G. Avinee (Rouen, FR)
Abstract Slides Video
Presentation thumbnail
Impact of cardiac damage extent on transcatheter aortic valve replacement outcome - a validation of a new staging system
Doctor M. Fukui (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Impact of aortic valve calcification on new onset conduction disturbance after transcatheter aortic valve replacement
Miss Y. Wang (Beijing, CN)
Abstract

Access the full session

Session thumbnail
Hot topics in valvular heart disease

The Event

Event poster

ESC Congress 2018

25 August 2018 11:54 CET
You may be interested in
thumbnail
Congress Presentation
The influence of the valve expansion on the hemodynamic outcome in valve-in-valve transcatheter aortic valve replacement
31 August 2025
thumbnail
Congress Session
Failing valves and beyond
19 May 2025
thumbnail
Congress Presentation
Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.
1 September 2019
thumbnail
Congress Presentation
TAVI durability
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources